Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Motos Galera (Barcelona, Spain), E. Barbeta (Barcelona, Spain), J. Bobi (Barcelona, Spain), H. Yang (Barcelona, Spain), M. Yang (Barcelona, Spain), G. Tanzella (Genoa, Italy), R. Cabrera (Barcelona, Spain), C. Vargas (Barcelona, Spain), P. Di Ginnatale (Pescara, Italy), S. Nogas (Genoa, Italy), M. Arrieta (Barcelona, Spain), L. Fernandez-Barat (Barcelona, Spain), R. Mellado (Barcelona, Spain), M. Rigol (Barcelona, Spain), G. Frigola (Barcelona, Spain), M. Ferrer (Barcelona, Spain), G. Li Bassi (Barcelona, Spain), A. Artigas (Barcelona, Spain), A. Torres (Barcelona, Spain). Novel swine ARDS model induced by Pseudomonas aeruginosa pneumonia and VILI. 2755

Member's Comments

No comment yet.

Related content which might interest you: Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response Source: Eur Respir J 2007; 30: 1167-1172 Year: 2007 Effects of glucocorticoids in ventilated piglets with severe pneumonia Source: Eur Respir J 2008; 32: 1037-1046 Year: 2008 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Aetiopathogenesis of VAP revisited Source: Eur Respir Mon 2011; 53: 1-10 Year: 2011 Pulmonary infections with pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004 Klebsiella pneumoniae outgrowth in ARDS lungs is influenced by the ventilation strategy used Source: Eur Respir J 2003; 22: Suppl. 45, 13s Year: 2003 Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Source: Eur Respir J 2006; 28: 974-979 Year: 2006 Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia Source: Eur Respir J 2008; 32: 1599-1606 Year: 2008 Pseudomonas aeruginosa infections Source: Respipedia Article Year: 2018 Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors Source: Eur Respir J 2010; 35: 598-615 Year: 2010 Animal models of VAP Source: Eur Respir Mon 2011; 53: 98-112 Year: 2011 The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Does a single Pseudomonas aeruginosa isolation predict COPD mortality? Source: Eur Respir J 2014; 44: 794-797 Year: 2014 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients? Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques Year: 2018 Early mortality in patients with community-acquired pneumonia: causes and risk factors Source: Eur Respir J 2008; 32: 733-739 Year: 2008 Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD) Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009